Ankle nerve stimulation for bladder problems after spinal cord injury
Tests TTNS, a skin-applied nerve stimulation, for overactive bladder in people with spinal cord injury.
Key facts
- Who runs it
- National University Hospital, Singapore
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- TTNS in SCI Patients With Neurogenic Detrusor Overactivity
- Status
- Not yet recruiting
- People taking part
- 12 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional
- Treatments tested
- TTNS
- Record updated
- 25 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a spinal cord injury and an overactive bladder caused by nerve damage (neurogenic detrusor overactivity). They will get skin-surface nerve stimulation at the ankle (TTNS) daily for 4 weeks.
- Age
- 21 Years to 70 Years
- Sex
- All sexes
- Disease stage
- Diagnosed spinal cord injury and diagnosed neurogenic detrusor overactivity. People must be able to tolerate a bladder pressure test (urodynamic study). People with spinal shock or lower motor neuron syndrome cannot join.
- Earlier treatment
- Cannot join after transcutaneous or percutaneous PTNS or sacral neuromodulation at any time, or botulinum toxin injection into the bladder muscle within the past 6 months.
Main reasons for not taking part
- Pacemaker, deep brain stimulator, other implanted electrical device, or ankle implant or ankle joint disease
- Sores or broken skin where the device is placed
- Active urinary tract infection, known bladder tumour or bladder stones
- Pregnancy
- Enlarged prostate (BPH) with blocked flow, mainly stress leakage, or past psychiatric conditions
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Aged between 21 years and 70 years old
- Clinical diagnosis of spinal cord injury
- Diagnosis of neurogenic detrusor overactivity
- Able to tolerate Urodynamic study
- Ability to provide informed consent
Who cannot take part
- Prior treatment with transcutaneous PTNS or percutaneous PTNS (any time), sacral neuromodulation (anytime) or intradetrusor botulinum toxin injection within the past 6 months
- Patients with active implantable device or ankle orthopaedic implant, Ankle articular diseases
- Active urinary tract infection
- Past medical history of psychiatric conditions
- Patients with lower motor neuron syndrome
- Pacemakers or implanted electrical devices, including deep brain stimulation
- Ulceration or broken skin in area of TTNS device placement
- Patients with BPH: predominantly voiding Lower Urinary Tract Symptoms (LUTS), Uroflow demonstrating obstructive pattern
- Pregnancy
- Known bladder tumour, urinary calculi
- Predominant stress urinary incontinence
- Patients with spinal shock
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 70 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective, single-arm, pilot study to assess effectiveness and tolerability of transcutaneous tibial nerve stimulation (TTNS) in managing neurogenic detrusor overactivity in spinal cord injury patients. 12 - 16 spinal cord injury patients with neurogenic detrusor overactivity will be recruited. The intervention includes administration of TTNS at the highest tolerated level for 20 minutes daily for 4 weeks, using a neuromodulation device -- Tensi+.
Read full original descriptionShow less
Outcome measures including Urodynamic Study (UDS) will be retrieved or collected at baseline and collected after the 4 weeks of TTNS administration. Other outcome measures include Overactive Bladder Questionnaire Short Form (OAB-Q-SF), which will be administered before and after TTNS administration, subject's level of discomfort and any adverse events experienced by the subject will be recorded after each intervention session and a bladder diary will be recorded weekly for subjects not on indwelling urinary catheters. A TTNS satisfaction survey will also be performed at the end of the study.
The group in the trial
- transcutaneous tibial nerve stimulationTreatment being tested
28 sessions of transcutaneous tibial nerve stimulation (TTNS) in 4 weeks
Treatment: TTNS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pilot Study to Evaluate the Effectiveness and Tolerability of Transcutaneous Tibial Nerve Stimulation (TTNS) in Management of Neurogenic Detrusor Overactivity in Patients With Spinal Cord Injuries.
- Plain-language title
- Ankle nerve stimulation for bladder problems after spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07785258, who can take part
- Record updated
- 25 August 2026